phenytoin has been researched along with losartan potassium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akpolat, T; Caglar, S; Sungur, A; Sungur, C; Turgan, C; Yasavul, U | 1 |
| Farooq, MU; Gupta, R; Kassab, M; Majid, A; Reeves, M; Zemke, D | 1 |
| Krzyzanski, W; Mager, DE; Yan, X | 1 |
3 other study(ies) available for phenytoin and losartan potassium
| Article | Year |
|---|---|
Unresponsiveness to human recombinant erythropoietin in an epileptic dialysis patient secondary to valproic acid toxicity.
Topics: Adult; Electrocardiography; Epilepsy, Tonic-Clonic; Erythropoietin; Female; Humans; Kidney Failure, Chronic; Phenytoin; Recombinant Proteins; Renal Dialysis; Valproic Acid | 1992 |
The effect of anticonvulsant drugs on the fibrinolytic activity of tissue plasminogen activator.
Topics: Adult; Anticonvulsants; Blood Coagulation; Drug Interactions; Erythropoietin; Female; Fibrinolytic Agents; Humans; In Vitro Techniques; Levetiracetam; Male; Phenobarbital; Phenytoin; Piracetam; Recombinant Proteins; Tissue Plasminogen Activator; Valproic Acid | 2008 |
Selection between Michaelis-Menten and target-mediated drug disposition pharmacokinetic models.
Topics: Antibodies, Monoclonal; Computer Simulation; Erythropoietin; Humans; Nonlinear Dynamics; Phenytoin; Recombinant Proteins | 2010 |